Shilpa Medicare P/B Ratio
Shilpa Medicare P/B ratio. Shilpa Medicare (SHILPAMED) P/B ratio is 7.04 (High), book value per share ₹1295.50 vs Healthcare average P/B of -0.3 — Very High - Significant premium, high growth expectations or speculative. Read Shilpa Medicare dividend payments for the complete payout history and dividend yield track record.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
SHILPAMED P/B Ratio — Valuation Insights & Book Value Analysis
Shilpa Medicare price-to-book ratio interpretation, valuation status and historical context — current P/B 7.04 (High). For live price, earnings yield and the full fundamental profile, see SHILPAMED share price screener.
- Stock appears overvalued with PB of 7.04, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 2156.4% above historical average
- Trading at premium to sector average PB of -0.3
Shilpa Medicare P/B Ratio Historical Trend
SHILPAMED annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Browse SHILPAMED financial statements for revenue, profit, balance sheet and cash flow data.
SHILPAMED Historical P/B Ratio — Book Value Per Share & Year-End Price
Shilpa Medicare annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 0.7 | ₹1295.5 | ₹900.70 | ₹2,591 | Low |
| 2025 | 0.14 | ₹2364.0 | ₹321.15 | ₹2,364 | Low |
| 2024 | 0.41 | ₹2000.0 | ₹816.35 | ₹1,800 | Low |
| 2023 | 0.17 | ₹1971.11 | ₹330.40 | ₹1,774 | Low |
| 2022 | 0.14 | ₹2012.22 | ₹278.25 | ₹1,811 | Low |
SHILPAMED vs Healthcare Peers — P/B Ratio Comparison
Shilpa Medicare P/B 7.04 vs Healthcare average -0.3, median 0.39 — range -7.62–0.89.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Chennai Meenakshi Multis… | CMMHOSP | -7.62 | ₹27 | Low |
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -1.2 | ₹39 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.75 | ₹128 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.18 | ₹43 | Low |